2024-03-31-accounts - Race Against Blood Cancer

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer Annual Report, Fiscal Year 2023-2024

The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the fiscal year 1st April 2023 to 31st March 2024.

In the UK blood cancer patients from a Global Majority background have a significantly higher postdiagnosis mortality rate when compared to White Northern European patients. A White Northern European patient has a 70% or more chance of finding a match compared to a 20% or less chance for a Global Majority patient.

Race Against Blood Cancer was founded in 2015 by a group of friends who received the devastating news of a close friend’s blood cancer diagnosis. A lifesaving match depends on finding a stem cell or bone marrow donor with a similar ethnicity as the patient and it was even more devastating to realise that the chance of finding a match was significantly lower because of a mixed ethnic background. This group of friends were inspired to join the fight for health equality and give every blood cancer patient the best possible chance of surviving blood cancer regardless of background.

At RABC our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match.

Our mission is to save more lives by addressing the stark inequality of finding a stem cell match for Global Majority blood cancer patients by recruiting more people from these backgrounds onto the UK’s register of stem cell and bone marrow donors.

To achieve our mission we deliver one of the only UK programmes aiming to engage the public in a face-to-face capacity and recruit new people from Global Majority backgrounds onto the donor register. We focus our efforts on partnering with organisations and in areas which have high levels of our target population, building trust and relationships with organisations and communities to recruit as many Global Majority donors as possible each year.

Our 'Save a Life’ Programme (SLP) has developed over 9-years and consists of Donor Drive events, where we directly sign people up to the stem cell and bone marrow donor register. We’ve recently added separate Education Talks, which raise awareness of the issue, where each talk is followed a week later by a Donor Drive event. This approach slows our recruitment in real terms but invests in longer-term attitude change in people we hope will become lifelong advocates. Our programme is delivered across the Midlands, and we have a national reach because the donor registry is accessed across the UK.

For countless people living with blood cancer and other blood disorders, the search for a matching stem cell donor is a race against time. Your willingness to donate could offer them the priceless gift of a second chance at life.

Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Youth Education Talks

Historically we’ve worked closely with local educational organisations including Shrewsbury College Group, Birmingham Newman University and Coventry University to deliver donor drives. This year we began tweaking our Save a Life Programme (SLP) approach towards a younger audience with the Youth Education Programme (YEP) in partnership with Anthony Nolan. This consists of delivering a talk aiming to raise awareness of the underrepresentation issue, bust the many myths that currently exist around the sign-up process, and educate young people on the simple process of becoming a stem cell or bone marrow donor. We then follow with our traditional Donor Drive, having warmed up our audience ahead of time, giving them time to discuss with their friends and families, and creating multiple opportunities for them to choose whether to donate by interacting twice over a week or so, instead of as a one-off. We encourage attendees to drive longevity by also encouraging attendees to volunteer for us on future donor drives and offer them the opportunity of being trained with us to equip them to run their own donor drives.

Donor Drives

We delivered 48 events (46 donor drives and 2 educational events) this year due to our increased focus on educational institutions, and the two-step Youth Education Programme (YEP). Each donor drive sees us set up a stall, at a University, Community Centre, sporting event or other high footfall area, and invite people to commit to join the register. Donors are given a simple kit to collect a saliva sample which we send off to one of two UK organisations (Anthony Nolan & DKMS) who manage the UK donor register, tissue typing laboratory and matching service. Donor drives are delivered by a team of dedicated volunteers and aim to simplify the donor sign up process and make it more accessible for everyone.

Employees and Governance

Race Against Blood Cancer is a registered charity and at present the core team includes one full time Engagement Manager, and one part time General Manager. At 1.6 FTE, our reach is much greater than our size suggests, and we rely heavily on an incredible team of around 20 volunteers to deliver the large number of events each year.

We are governed by a racially diverse Board of Trustees, led by our Chair, Jacob Knox-Hooke.

Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Achievements and performance

Save a Life Programme (Donor Recruitment)

In 2023/24 we delivered 48 events (46 donor drives and 2 educational drives) and recruited 576 new people onto the stem cell and bone marrow donor register. Our increased educational activity has impacted our number of sign-ups, as we play the longer game, investing our time in those who we hope will become longer term supporters and advocates. Of these stem cell donors, 38% are from our target group compared to an average of 23% from the other donor recruiting organisations.

As a result of previous years’ achievements, an estimated 15 of the stem cell donors we recruited in FY23/24 were potential matches for patients in need.

Since we started nine years ago, we have saved more than 12 lives, with donors all coming from the pool of more than 12,000 donors recruited by RABC since 2015.

FY23/24 in Numbers
Total events	48 (46 + 2)
Consisting of: Education Drives	2
Consisting of: Donor Drives	46
Total Sign-Ups	586
Percentage of Global Majority Sign-ups	38%*

*38% based on donor drives conducted for Anthony Nolan, DKMS figures are delayed

Our spokesperson at Anthony Nolan said of our partnership:

“Race Against Blood Cancer (RABC) and Anthony Nolan (AN) have been working in Partnership since 2019, and really stepped up in activity from 2021 when RABC ran a series of very successful donor recruitment events with the National Citizen Service. At the end of 2023, we updated our recruitment agreement and RABC proposed an ambitious recruitment strategy and KPIs, which I am delighted to say they have surpassed.

It has been so impressive to see RABC pivot their approach to recruitment this year to engage more young people - forging new connections, trialling new approaches and successfully shifting their focus to a younger, more targeted audience...so they can reach even more young people where they’re at; share facts, bust myths and help each individual to make a safe, informed decision about donation.

Race Against Blood Cancer set out to recruit 300 people to the register across the first 3 months of this year, to recruit quality donors who we know will provide the best possible outcomes for patients.

Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Part of this is recruiting young donors, between the ages of 16-23. 84% of RABC’s recruitment is people aged 16-23 (compared to Anthony Nolan overall which is 80%). The other key area of focus is recruiting more donors from minority ethnic backgrounds as we are committed, at RABC and AN, to ensuring that every patient has access to a stem cell transplant. 38% of the people RABC recruited are from minority ethnic backgrounds, compared to 23% on average across Anthony Nolan. Not only are RABC committed to recruiting donors, they have demonstrated that they’re committed to recruiting quality donors who will go on to save the lives of patients now and in the future.

We're excited to continue to grow our partnership with Race Against Blood Cancer, and can’t wait to see the lifesaving impact they have in the local community and beyond!”

Fundraising

Delivering our essential programme of work is dependent on our fundraising efforts which are led by the General Manager. In FY21/22 we invested in hiring a new General Manager primarily to support our ability to generate funds. This role has taken time to bed in with fundraising income remaining static at £25k in FY22/23 while operating costs increased to £50k. By FY23/24 we have seen the return on this investment with £60k raised because of concerted efforts by the General Manager and Trustees to ensure the sustainable finances and the security of the organisation.

Income comes primarily from Trusts and Grants (90%) with individual donations and individual supporters fundraising effort making up the remainder (10%).

In 2022 we received funding to re-develop our website, and the work is underway. Our vision is for our website to enhance our brand awareness and allow us to better celebrate our successes, host patient appeals, and actively engage with our audience. This work has been tendered out and we have successfully contracted this work to Webbed Feet developers (late 2023).

Collaboration and strategic impact

In this period, we contributed to the inaugural ‘Where Are the Nation’s Donors’ report commissioned by the new All Party Parliamentary Group (APPG) ‘Ethnicity Transfusion and Transplantation’, helping to bring attention to the stark health inequality.

We envisage more work to be done with regards to our digital engagement to increase awareness through online media. Over the last year, we have continued to share case studies of those affected by blood cancer and have seen an increase in individuals holding their own ‘in-support of’ fundraising events to harness much needed funds for our work.

For the first time, we have secured a charity Ambassador, an up-and-coming boxer from the Shropshire area, and are partnering with him to put on events to bring more attention to the cause and the charity.

Through the NBTA and close collaboration with other small charities, we have seen the Aligned Registry (AN, DKMS, WBMDR and NHSBT) increase their ethnic minority donor targets and enhance their contractual alignment into 2024 and beyond. We have established an ongoing series of

Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

meetings with the Aligned Registry, with the goal of collaborating more closely, and the hope of taking more responsibility for ethnic minority recruitment.

Acknowledgements

The Trustees would like to thank the following individuals, companies and charitable trusts and organisations for their support throughout 2023/24:

----- Start of picture text -----
10,000 Donors Heart of Worcestershire College, Birmingham
African Caribbean Leukaemia Trust (ACLT) JC Race Solutions, Staffordshire
Anthony Nolan Joseph Chamberlain College, Birmingham
Birmingham Newman University National BAME Transplant Association (NBTA)
Coventry College, Coventry Newcastle and Stafford Colleges Group
Coventry University, Coventry Pure Gym, Broad Street Birmingham
DKMS UK Quynh Tran (designer)
Dudley College of Technology, Dudley Roger Counter Foundation
Geraldine Mollard (designer) Roy Castle Lung Cancer Foundation, Cannock Chase
Gnosall 10K, Gnosall Sandwell College, Birmingham
Halesowen College, Birmingham Shrewsbury College Group, Staffordshire
----- End of picture text -----

Shrewsbury Town FC, Shrewsbury South & City College Birmingham, Birmingham Stoke-on-Trent College, Stoke Sue Harris Trust Team Margot Telford Land Registry, Telford Telford Park Run, Telford The National Lottery The Wrekin Housing Group, Telford

Statement from the Chair of Trustees

Collaboration has been key to a successful year, as we continue to build post-pandemic momentum with our Youth Education Programme, contribution to the new APPG report and our website redevelopment. Landing our first ambassador has been an exciting development, preparing us to leverage his audience to grow our awareness in the Shropshire area.

We continue to strengthen our partnerships and evolve our structural approach to engaging volunteers to offer pro bono support with projects such as designing new marketing material.

We aim to continue to increase our attractiveness to funders to strengthen our foundations and grow our operation, with the future ambition over the next three years to get ourselves into a position to begin scaling the charity operations up.

Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer

Charity No. 1162696 Company No. CE005053

Trustees' Report and Unaudited Accounts

31 March 2024

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Contents

	Pages
Trustees' Annual Report	6
Independent Examiner's Report	7
Statement of Financial Activities	8
Summary Income and Expenditure Account	9
Balance Sheet	10
Statement of Cash flows	11
Notes to the Accounts	12 to 17
Detailed Statement of Financial Activities	18 to 19

Page 5

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer

Trustees Annual Report

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2024.

REFERENCE AND ADMINISTRATIVE DETAILS

Company No. CE005053

Charity No. 1162696

Registered Office

71-75 Shelton Street Covent Garden London WC2H 9JQ

Directors and Trustees

The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year:

J. Bates G. Fiske D. Gardner M.M. Gardner J.I.B. Knox-Hooke H. Shah B. Westwood

Accountants

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).

Signed on behalf of the board

J.I.B. Knox-Hooke Trustee 31 January 2025

Page 6

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Independent Examiners Report

Independent Examiner's Report to the trustees of Race Against Blood Cancer

I report to the charity trustees on my examination of the financial statements of Race Against Blood Cancer for the year ended 31 March 2024.

Responsibilities and basis of report

As the charity's trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act.

Having satisfied myself that the financial statements of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe:

accounting records were not kept in accordance with section 386 of the 2006 Act ; or
the financial statements do not accord with those records; or
the financial statements do not comply with the accounting requirements under section 396 of the 2006 Act other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination; or
the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

CPAA

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield

HD1 5JL 31 January 2025

Page 7

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Statement of Financial Activities

for the year ended 31 March 2024

Unrestricted funds 2024 £ 14,385 300	Restricted funds 2024 £ 20,000 8,557	Total funds 2024 £ 34,385 8,857	Total funds 2023 £ 6,647 18,525
14,685 694 24,203	28,557 - 34,860	43,242 694 59,063	25,172 795 49,261
24,897 -	34,860 -	59,757 -	50,056 -
(10,212) -	(6,303) -	(16,515) -	(24,884) -
(10,212)	(6,303)	(16,515)	(24,884)
(10,212) 8,442	(6,303) 13,300	(16,515) 21,742	(24,884) 46,626
(1,770)	6,997	5,227	21,742

Page 8

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Summary Income and Expenditure Account

for the year ended 31 March 2024

Income Gross income for the year Expenditure Interest payable Total expenditure for the year Net expenditure before tax for the year Net expenditure for the year	2024 £ 43,242 43,242 59,536 221 59,757 (16,515) (16,515)	2023 £ 25,172
		25,172
		49,761 295
		50,056
		(24,884)
		(24,884)

Page 9

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Balance Sheet

at 31 March 2024

Company No. CE005053 Notes 2024 £ Current assets Cash at bank and in hand 13,758 13,758 Creditors:Amount falling due within one year 10 (4,502) Net current assets 9,256 Total assets less current liabilities 9,256 Creditors:Amounts falling due after more than one year 11 (4,029) Net assets excluding pension asset or liability 5,227 Total net assets 5,227 The funds of the charity Restricted funds 12 Restricted income funds 6,997 6,997 Unrestricted funds 12 General funds (1,770) (1,770) Reserves 12 Total funds 5,227	2023 £ 32,725
	32,725 (3,980)
	28,745 28,745 (7,003)
	21,742
	21,742
	13,300
	13,300 8,442
	8,442
	21,742

These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

For the year ended 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

Approved by the board on 31 January 2025

And signed on its behalf by:

J.I.B. Knox-Hooke Trustee

31 January 2025

Page 10

for the year ended 31 March 2024 Cash flows from operating activities Net expenditure per Statement of Financial Activities Adjustments for: Dividends, interest and rents from investments Increase in trade and other payables Net cash used in operating activities Cash flows from investing activities Dividends, interest and rents from investments Net cash from investing activities Cash flows from financing activities Repayment of borrowings Net cash used in financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year Components of cash and cash equivalents Cash and bank balances Race Against Blood Cancer Statement of Cash flows Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC	2024 £ (16,515) (8,857) 522 (24,850) 8,857 8,857 (2,974) (2,974) (18,967) 32,725 13,758 13,758 13,758	2023 £ (24,884) (18,525) 290
		(43,119) 18,525
		18,525
		(2,900)
		(2,900)

		(27,494)
		60,219
		32,725

		32,725

		32,725

Page 11

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer

Notes to the Accounts

for the year ended 31 March 2024

1 Accounting policies

Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Change in basis of accounting or to previous accounts

There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.

Fund accounting

Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity.
Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal.

Income

Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability.
Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income.
Volunteer help The value of any volunteer help received is not included in the accounts.

Expenditure

Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates.
Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs.
Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs.
Other expenditure These are support costs not allocated to a particular activity.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Page 12

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer

Notes to the Accounts

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand.

Trade and other creditors

Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Pension costs

The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

2 Company status

The company is a private company limited by guarantee and consequently does not have share capital.

3 Statement of Financial Activities - prior year

Income and endowments from: Donations and legacies Other Total Expenditure on: Raising funds Other Total Net income Net income before other gains/(losses) Other gains and losses: Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward	Unrestricted funds 2023 £ 6,647 - 6,647 795 6,021 6,816 (169) (169) (169) 8,611 8,442	Restricted funds 2023 £ - 18,525 18,525 - 43,240 43,240 (24,715) (24,715) (24,715) 38,015 13,300	Total funds 2023 £ 6,647 18,525
			25,172 795 49,261
			50,056
			(24,884)
			(24,884)
			(24,884) 46,626
			21,742

Page 13

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer

Notes to the Accounts

4 Income from donations and legacies

Unrestricted £ 10,494 3,831 60 14,385 Unrestricted £ 300 300	Restricted £ - 20,000 - 20,000 Restricted £ 8,557 8,557	Total 2024 £ 10,494 23,831 60 34,385 Total 2024 £ 8,857 8,857	Total 2023 £ 3,399 3,188 60
			6,647
			Total 2023 £ 18,525
			18,525

Unrestricted £ 221 21,594 1,454 934 24,203	Unrestricted £ 62 632 694 Restricted £ - 28,950 1,560 4,350 34,860 2024 £ 650	Total 2024 £ 62 632 694 Total 2024 £ 221 50,544 3,014 5,284 59,063	Total 2023 £ 204 591
			795
			Total 2023 £ 295 46,174 1,427 1,365
			49,261
			2023 £ 650

Page 14

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Notes to the Accounts

Race Against Blood Cancer Notes to the Accounts Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC
9 Staff costs Salaries and wages Pension costs No employee received emoluments in excess of £60,000. 10 Creditors: amounts falling due within one year Bank loans and overdrafts Other taxes and social security Other creditors Accruals 11 Creditors: amounts falling due after more than one year Bank loans and overdrafts	2024 49,530 1,014 50,544 2024 £ 3,195 445 212 650 4,502 2024 £ 4,029 4,029	2023 45,273 901
		46,174
		2023 £ 3,195 560 225 -
		3,980
		2023 £ 7,003
		7,003

Page 15

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer

Notes to the Accounts

12 Movement in funds

Incoming resources (including other gains/losses ) £ 20,000 8,557 - 28,557 14,685 43,242	Resources expended £ (20,000) (1,560) (13,300) (34,860) (24,897) (59,757)	At 31 March 2024 £ - 6,997 -
		6,997
		(1,770)
		5,227





At 1 April 2023 £	Unrestricted funds £ 9,256 (4,029) 5,227 Cash flows £	Total £ 9,256 (4,029)
		5,227
		At 31 March 2024 £
32,725	(18,967)	13,758
32,725 (10,198) (10,198) 22,527	(18,967) 2,974 2,974 (15,993)	13,758 (7,224)
		(7,224)
		6,534

Page 16

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer Notes to the Accounts

15 Commitments

Operating lease commitments

Annual commitments under non-cancellable operating leases are as follows:

	2024	2024	2023	2023
	Land and buildings	Other	Land and buildings	Other
	£	£	£	£
Operating leases with expiry date:
*Pension commitments*
		2024		2023
		£		£
The pension cost charge to the company
amounted to:		1,014		901

16 Related party disclosures Controlling party

The company is limited by guarantee and has no share capital; thus no single party controls the company.

Page 17

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC Race Against Blood Cancer

Detailed Statement of Financial Activities

for the year ended 31 March 2024

Income and endowments from: Donations and legacies Donations From Events General Donations Regular Donations Other Other Grant Income Total income and endowments Expenditure on: Costs of generating donations and legacies Adhoc Donations MyDonate Donations From Events Total of expenditure on raising funds Other expenditure Bank loan and overdraft interest payable Employee costs Salaries/wages Pension costs General administrative costs, including depreciation and amortisation Equipment expensed General insurances Software, IT support and related costs Stationery and printing Telephone, fax and broadband Legal and professional costs Accountancy and bookkeeping Consultancy fees	Unrestricte d funds 2024 £ 10,494 3,831 60 14,385 300 300 14,685 62 632 694 694 221 221 20,580 1,014 21,594 - 233 420 162 639 1,454 934 -	Restricted funds 2024 £ - 20,000 - 20,000 8,557 8,557 28,557 - - - - - - 28,950 - 28,950 - - 1,560 - - 1,560 - 4,350	Total funds 2024 £ 10,494 23,831 60 34,385 8,857 8,857 43,242 62 632 694 694 221 221 49,530 1,014 50,544 - 233 1,980 162 639 3,014 934 4,350	Total funds 2023 £ 3,399 3,188 60
				6,647
				18,525
				18,525
				25,172 204 591
				795
				795 295
				295
				45,273 901
				46,174
				191 337 399 64 436
				1,427
				765 600

Page 18

Docusign Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC

Race Against Blood Cancer Detailed Statement of Financial Activities

Race Against Blood Cancer Detailed Statement of Financial Activities Envelope ID: B856F716-2C51-411F-9015-4225C87B9FEC
Total of expenditure of other costs Total expenditure Net gains on investments Net expenditure Net expenditure before other gains/(losses) Other Gains Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward	934 24,203 24,897 - (10,212) (10,212) - (10,212) 8,442 (1,770)	4,350 34,860 34,860 - (6,303) (6,303) - (6,303) 13,300 6,997	5,284 59,063 59,757 - (16,515) (16,515) - (16,515) 21,742 5,227	1,365

				49,261
				50,056 -
				(24,884)
				(24,884) -
				(24,884)
				46,626
				21,742

Page 19